Covista (CVSA) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
29 Oct, 2026Executive summary
Q1 FY27 enrollment rose 7.6% to 104,713, revenue increased 10.7% to $511.5M, and adjusted EPS grew 25.1% to $2.19; FY27 revenue and adjusted EPS guidance increased.
Results reflected enrollment and tuition growth across all three segments, with adjusted EBITDA margin expanding 140 bps to 25.6%.
Purpose at Scale is a three-year strategy focused on operational excellence, platform extension, employer integration, and technology.
Financial highlights
Revenue was $511.5M versus $462.3M; adjusted EBITDA rose 17.1% to $131.2M from $112.0M.
Adjusted net income increased to $75.8M from $64.9M; adjusted EPS was $2.19 versus $1.75. GAAP net income was $67.4M versus $61.8M, and diluted EPS was $1.95 versus $1.67.
Operating income was $98.0M versus $85.5M; adjusted operating income rose 18.1% to $106.6M from $90.3M.
Operating cash flow from continuing operations was $114.3M versus $130.6M; quarterly capital expenditures were $37.6M versus $16.0M.
Outlook and guidance
FY27 revenue guidance increased to $2.060B–$2.095B from $2.050B–$2.090B, with expected YoY growth of 5.5%–7%.
FY27 adjusted EPS guidance increased to $9.00–$9.20 from $8.90–$9.15, with expected YoY growth of 9%–11.5%.
Full-year adjusted EBITDA margin expansion remains guided at 0–50 bps; Q1's 140 bps expansion is not a run-rate expectation. Capex is expected above FY26 levels, weighted toward H1.
A Walden academic week shifts revenue and adjusted EBITDA from Q2 to Q3, with no full-year impact; the shift is $18M.
Latest events from Covista
- Voting clarification: broker non-votes affect quorum and auditor ratification only.CVSA
Proxy filing - FY26 outperformance closes one strategy; a new plan targets growth through FY29.CVSA
Proxy filing - Board backs all four voting matters at the November 11, 2026 virtual meeting.CVSA
Proxy filing - Sustained growth, campus expansion, and strategic partnerships drive a leading healthcare education platform.CVSA
2026 Jefferies Healthcare Services and Technology Conference - Double-digit EPS growth, record enrollments, and strong FY27 outlook delivered.CVSA
Q4 2026 - Record enrollment and revenue growth, raised guidance, and strong capital allocation.CVSA
Q3 2026 - Enrollment and revenue growth drive strong earnings and positive 2026 outlook.CVSA
Q1 2026 - Double-digit enrollment and revenue growth drive record results and strong FY25 outlook.CVSA
Q4 2024 - Record enrollment and margin gains highlight strong growth in healthcare education.CVSA
Baird 2024 Global Consumer, Technology & Services Conference